EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

High-Sensitivity C-Reactive Protein and Residual Inflammatory Risk in Coronary Artery Disease: The Pathophysiology, Prognosis, and Emerging Therapies

Masahiro Katamine, Yoshiyasu Minami, Junya Ako

Journal of Atherosclerosis and Thrombosis · 01.01.2026 · 33 (1) · 1-12

DOI: 10.5551/jat.rv22044 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Atherosclerosis and Thrombosis, erschienen am 01.01.2026. Verfasst von Masahiro Katamine und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Kitasato University School of Medicine. Hauptthemen laut MEDLINE: C-Reactive Protein, Coronary Artery Disease, Inflammation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation plays a crucial role in the initiation, progression, and destabilization of atherosclerotic plaques and it contributes to recurrent cardiovascular events in patients with coronary artery disease (CAD). High-sensitivity C-reactive protein (hsCRP) is a well-established biomarker of systemic inflammation and it is a predictor of adverse outcomes, independent of low-density lipoprotein cholesterol (LDL-C) levels. Elevated hsCRP levels are consistently associated with higher event rates in both chronic and acute coronary syndromes, thus reflecting the residual inflammatory risk not addressed by lipid-lowering therapy or revascularization. Imaging studies have revealed that higher hsCRP levels correlate with a greater plaque burden and vulnerability. Recent trials have shown that anti-inflammatory therapies, including low-dose colchicine and interleukin-6 inhibition, can reduce this residual risk, while agents such as glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors, and bempedoic acid offer additional anti-inflammatory effects. The integration of anti-inflammatory strategies with intensive lipid management may thus provide additional cardiovascular benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

C-Reactive ProteinCoronary Artery DiseaseInflammationHumansPrognosisBiomarkersRisk FactorsAnti-Inflammatory Agents

Stichwörter der Autor:innen

Acute coronary syndromeChronic coronary syndromeColchicineInflammationLipid-lowering therapy

Substanzen

C-Reactive ProteinBiomarkersAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Kitasato University School of Medicine.

Zitieren

APA

Katamine, M., Minami, Y., & Ako, J. (2026). High-Sensitivity C-Reactive Protein and Residual Inflammatory Risk in Coronary Artery Disease: The Pathophysiology, Prognosis, and Emerging Therapies. Journal of Atherosclerosis and Thrombosis, 33(1), 1-12. https://doi.org/10.5551/jat.rv22044

Vancouver

Katamine M, Minami Y, Ako J. High-Sensitivity C-Reactive Protein and Residual Inflammatory Risk in Coronary Artery Disease: The Pathophysiology, Prognosis, and Emerging Therapies. Journal of Atherosclerosis and Thrombosis. 2026;33(1):1-12. doi:10.5551/jat.rv22044

BibTeX
@article{Katamine2026,
  author = {Katamine, Masahiro and Minami, Yoshiyasu and Ako, Junya},
  title = {High-Sensitivity C-Reactive Protein and Residual Inflammatory Risk in Coronary Artery Disease: The Pathophysiology, Prognosis, and Emerging Therapies},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2026},
  volume = {33},
  number = {1},
  pages = {1--12},
  doi = {10.5551/jat.rv22044}
}
Kostenlos starten →